Publicaciones en colaboración con investigadores/as de Danish Cancer Society (38)

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2019

  1. Association of menopausal characteristics and risk of coronary heart disease: A pan-European case-cohort analysis

    International Journal of Epidemiology, Vol. 48, Núm. 4, pp. 1275-1285

  2. Association of plasma Vitamin D metabolites with incident type 2 diabetes: EPIC-InterAct case-cohort study

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 4, pp. 1293-1303

  3. Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3303-3312

  4. Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study

    Journal of Nutrition, Vol. 149, Núm. 11, pp. 1985-1993

2018

  1. Air pollution exposure during pregnancy and symptoms of attention deficit and hyperactivity disorder in children in Europe

    Epidemiology, Vol. 29, Núm. 5, pp. 618-622

  2. Circulating fetuin - A and risk of type 2 diabetes: A mendelian randomization analysis

    Diabetes, Vol. 67, Núm. 6, pp. 1200-1205

  3. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    International Journal of Cancer, Vol. 142, Núm. 3, pp. 449-459

  4. Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe: Results from the EPIC prospective cohort study

    PLoS Medicine, Vol. 15, Núm. 9

  5. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2351-2358

  6. Risk thresholds for alcohol consumption: combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies

    The Lancet, Vol. 391, Núm. 10129, pp. 1513-1523

2017

  1. Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 140, Núm. 10, pp. 2246-2255

  2. Consumption of fish is not associated with risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition (EPIC) study

    Journal of Nutrition, Vol. 147, Núm. 7, pp. 1366-1373

  3. Erratum to “The histology of ovarian cancer: Worldwide distribution and implications for international survival comparisons (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 405–413](S0090825816314974)(10.1016/j.ygyno.2016.10.019)

    Gynecologic Oncology

  4. Erratum to “Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2)” [Gynecol. Oncol. 144 (2017) 396–404](S009082581631575X)(10.1016/j.ygyno.2016.11.019)

    Gynecologic Oncology

  5. Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance

    Nature Genetics, Vol. 49, Núm. 1, pp. 17-26

  6. The influence of meteorological factors and atmospheric pollutants on the risk of preterm birth

    American Journal of Epidemiology, Vol. 185, Núm. 4, pp. 247-258

2016

  1. Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: A meta-analysis

    JAMA - Journal of the American Medical Association, Vol. 316, Núm. 13, pp. 1383-1391

2015

  1. Age and case mix-standardised survival for all cancer patients in Europe 1999-2007: Results of EUROCARE-5, a population-based study

    European Journal of Cancer, Vol. 51, Núm. 15, pp. 2120-2129

  2. Global surveillance of cancer survival 1995-2009: Analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)

    The Lancet, Vol. 385, Núm. 9972, pp. 977-1010